An article written by Jonathan Roses and Alexander Lee, associate at Hoffmann Eitle, titled "Doctrine of Equivalents in US and European Patent Law" was published in The Pharma Letter. Read more (subscription required).
This article is the fourth in a series exploring legal issues relevant to the life sciences industry and how they vary between the two major jurisdictions of the United States and Europe. The other articles included in this series are:
- The Intersection of Regulatory and Patent Exclusivities for the Life Sciences Industry: A Comparative Overview of American and European Schemes
- Double Patenting in the USA and Europe
- Salt and Solid Form Issues in US and European Patents
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.